Versant Venture Capital VI, L.P.

GLUE

Versant Venture Capital VI, L.P. serves as an insider at Monte Rosa Therapeutics, Inc. (GLUE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$5.06M

Total Sells

5 trades

$20.42M

Net Position

Net Seller

$15.36M

Companies Traded

GLUE, TPST, IPSC, LENZ

Active Period

Jun 2021 – Oct 2024

7 total trades

Most Recent

Sell GLUE

Oct 30, 2024 · $1.49M

Versant Venture Capital VI, L.P.'s Insider Trading at Monte Rosa Therapeutics, Inc. (GLUE)

Buys

0 · $0.00

Sells

3 · $12.29M

Total Shares Bought

Total Shares Sold

1,857,674

GLUE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 30, 2024	Sell	157,895	$9.44	$1.49M	2,007,948
Sep 24, 2024	Sell	1,132,566	$6.53	$7.40M	5,099,336
Sep 13, 2024	Sell	567,213	$6.00	$3.40M	6,257,218

Versant Venture Capital VI, L.P.'s Insider Trading at Century Therapeutics, Inc. (IPSC)

Buys

1 · $2.00M

Sells

1 · $7.17M

Total Shares Bought

100,000

Total Shares Sold

550,000

IPSC Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 11, 2022	Sell	550,000	$13.03	$7.17M	11,816,814
Jun 23, 2021	Buy	100,000	$20.00	$2.00M	714,095

Versant Venture Capital VI, L.P.'s Insider Trading at LENZ Therapeutics, Inc. (LENZ)

Buys

1 · $3.06M

Sells

0 · $0.00

Total Shares Bought

180,000

Total Shares Sold

LENZ Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 1, 2021	Buy	180,000	$17.00	$3.06M	1,707,719

Versant Venture Capital VI, L.P.'s Insider Trading at Tempest Therapeutics, Inc. (TPST)

Buys

0 · $0.00

Sells

1 · $967.0K

Total Shares Bought

Total Shares Sold

787,999

TPST Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 12, 2024	Sell	787,999	$1.23	$967.0K	597,940

Related Insiders

Gregory Russotti

See Remarks

IPSCSell · Jun 9, 2026

Douglas Carr

SVP Finance & Operations

IPSCSell · Jun 9, 2026

Markus Warmuth

director, officer: President & CEO

GLUESell · Jun 2, 2026

Sharon Townson

officer: Chief Scientific Officer

GLUESell · Jun 1, 2026

Jennifer Champoux

officer: Chief Operating Officer

GLUESell · May 28, 2026

Anthony M. Manning

director

GLUESell · May 22, 2026

Philip Nickson

officer: Chief Business & Legal Officer

GLUESell · Apr 10, 2026

Matthew Angel

director, 10 percent owner, officer: CEO and President

TPSTBuy · Mar 25, 2026

Explore More Insider Trading Data

GLUE Insider Trading Activity

View all insider trades at Monte Rosa Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity